| Unravelling tumour heterogeneity by single-cell profiling of circulating tumour cells L Keller, K Pantel Nature Reviews Cancer 19 (10), 553-567, 2019 | 523 | 2019 |
| Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond L Keller, Y Belloum, H Wikman, K Pantel British journal of cancer 124 (2), 345-358, 2021 | 361 | 2021 |
| NaLi-H1: A universal synthetic library of humanized nanobodies providing highly functional antibodies and intrabodies S Moutel, N Bery, V Bernard, L Keller, E Lemesre, A De Marco, L Ligat, ... Elife 5, e16228, 2016 | 309 | 2016 |
| Biology and clinical relevance of EpCAM L Keller, S Werner, K Pantel Cell stress 3 (6), 165, 2019 | 192 | 2019 |
| Current and future clinical applications of ctDNA in immuno-oncology JC Stadler, Y Belloum, B Deitert, M Sementsov, I Heidrich, C Gebhardt, ... Cancer Research 82 (3), 349-358, 2022 | 108 | 2022 |
| Targeted sequencing of plasma cell-free DNA to predict response to PD1 inhibitors in advanced non-small cell lung cancer N Guibert, G Jones, JF Beeler, V Plagnol, C Morris, J Mourlanette, ... Lung Cancer 137, 1-6, 2019 | 100 | 2019 |
| Monitoring of KRAS-mutated ctDNA to discriminate pseudo-progression from true progression during anti-PD-1 treatment of lung adenocarcinoma N Guibert, J Mazieres, M Delaunay, A Casanova, M Farella, L Keller, ... Oncotarget 8 (23), 38056, 2017 | 94 | 2017 |
| Molecular mechanisms of cancer metastasis via the lymphatic versus the blood vessels SP Leong, K Naxerova, L Keller, K Pantel, M Witte Clinical & Experimental Metastasis 39 (1), 159-179, 2022 | 85 | 2022 |
| Epithelial keratins: Biology and implications as diagnostic markers for liquid biopsies S Werner, L Keller, K Pantel Molecular aspects of medicine 72, 100817, 2020 | 76 | 2020 |
| Monitoring KRAS mutations in circulating DNA and tumor cells using digital droplet PCR during treatment of KRAS-mutated lung adenocarcinoma N Guibert, A Pradines, M Farella, A Casanova, S Gouin, L Keller, G Favre, ... Lung cancer 100, 1-4, 2016 | 67 | 2016 |
| Activity-based protein profiling in bacteria: Applications for identification of therapeutic targets and characterization of microbial communities LJ Keller, BM Babin, M Lakemeyer, M Bogyo Current opinion in chemical biology 54, 45-53, 2020 | 58 | 2020 |
| Chemiluminescent Protease Probe for Rapid, Sensitive, and Inexpensive Detection of Live Mycobacterium tuberculosis BM Babin, G Fernandez-Cuervo, J Sheng, O Green, AA Ordonez, ... ACS central science 7 (5), 803-814, 2021 | 50 | 2021 |
| RhoB modifies estrogen responses in breast cancer cells by influencing expression of the estrogen receptor C Médale-Giamarchi, I Lajoie-Mazenc, E Malissein, E Meunier, ... Breast Cancer Research 15, 1-13, 2013 | 41 | 2013 |
| A targeted protein degradation cell-based screening for nanobodies selective toward the cellular RHOB GTP-bound conformation N Bery, L Keller, M Soulie, R Gence, AL Iscache, J Cherier, S Cabantous, ... Cell chemical biology 26 (11), 1544-1558. e6, 2019 | 40 | 2019 |
| Fluorescent Triazole Urea Activity‐Based Probes for the Single‐Cell Phenotypic Characterization of Staphylococcus aureus L Chen, LJ Keller, E Cordasco, M Bogyo, CS Lentz Angewandte Chemie 131 (17), 5699-5703, 2019 | 40 | 2019 |
| Detection and monitoring of the BRAF mutation in circulating tumor cells and circulating tumor DNA in BRAF-mutated lung adenocarcinoma N Guibert, A Pradines, A Casanova, M Farella, L Keller, JC Soria, G Favre, ... Journal of Thoracic Oncology 11 (9), e109-e112, 2016 | 40 | 2016 |
| Intra-patient heterogeneity of circulating tumor cells and circulating tumor DNA in blood of melanoma patients K Gorges, L Wiltfang, TM Gorges, A Sartori, L Hildebrandt, L Keller, ... Cancers 11 (11), 1685, 2019 | 39 | 2019 |
| Early Circulating Tumour DNA Variations Predict Tumour Response in Melanoma Patients Treated with Immunotherapy. L Keller, N Guibert, A Casanova, S Brayer, M Farella, M Delaunay, ... Acta Dermato-Venereologica 99 (2), 2019 | 34 | 2019 |
| Selection and characterization of a nanobody biosensor of GTP-bound RHO activities L Keller, N Bery, C Tardy, L Ligat, G Favre, TH Rabbitts, A Olichon Antibodies 8 (1), 8, 2019 | 28 | 2019 |
| Liquid biopsy of non-plasma body fluids in non-small cell lung cancer: look closer to the tumor! L Durin, A Pradines, C Basset, B Ulrich, L Keller, V Dongay, G Favre, ... Cells 9 (11), 2486, 2020 | 26 | 2020 |
